Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

BAX Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

Baxter International Inc.NYSE: BAX

Other Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026

Other non-current liabilities rises 9.2% from a year ago

Other non-current liabilities stood at $1.2B at the end of Q2 FY2026, up 9.2% from a year earlier and down 5.1% from the prior quarter. Over 3 fiscal years it compounded at -14.8% a year.

Context

  • Other non-current liabilities amounted to 6.1% of total assets at the end of Q2 FY2026, up 0.8 pp from a year earlier.
  • Other non-current liabilities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +9.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.2B-5.1% QoQ
Last fiscal yearDec 2025
$783M-47.3% YoY
Year agoJun 2025
$1.1B+9.2% since
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+9.2%——
1 year-47.3%——
3-year CAGR-14.8%——
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
783M USD
Year-over-year change
-47.3%
4-year CAGR
-14.2%

Other Non-current Liabilities vs competitors

How BAX compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +9.2% is the 2nd highest of 4, against a peer median of +0.3%.
  • Other non-current liabilities amounts to 6.1% of total assets for BAX, versus a peer median of 2.7%.
BAX Competitors
Other Non-current Liabilities for BAX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DVADaVita Inc.Jun 2026$2.29B USD+1360.2%—12.9%
FMSFresenius Medical Care AG & Co. KGaAJun 2026€1.27B EUR+0.3%+3.0%4.1%
BAXBaxter International Inc.Jun 2026$1.2B USD+9.2%-14.8%6.1%
ICUIICU Medical, Inc.Jun 2026$56.02M USD-25.7%-31.8%1.4%
INFUInfuSystem Holdings, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding BAX) —+0.3%-14.4%2.7%

Competitors are the stored peer set for BAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.95B1.72B3.08B1.76B1.97B
Short-term Investments00000
Net Receivables2.71B2.62B1.77B1.73B1.93B
Inventory2.45B2.68B1.92B2.05B2.23B
Other Current Assets390M618M2.51B2.95B479M
Total Current Assets8.87B8.01B9.6B8.85B6.87B
Property, Plant & Equipment (Net)5.81B5.24B3.21B3.18B3.19B
Goodwill9.84B6.45B5.79B5.28B4.93B
Intangible Assets7.79B6.79B5.92B5.22B4.37B
Long-term Investments195M247M136M109M103M
Tax Assets376M280M263M204M0
Other Non-current Assets642M1.27B3.36B2.94B596M
Total Non-current Assets24.65B20.28B18.68B16.93B13.18B
Total Assets33.52B28.29B28.28B25.78B20.06B
Account Payables1.25B1.11B881M968M999M
Short-term Debt511M1.4B2.67B2.75B84M
Tax Payables264M254M268M217M0
Deferred Revenue162M154M128M131M141M
Other Current Liabilities751M618M1.64B1.53B1.22B
Total Current Liabilities4.24B4.75B6.5B6.51B2.97B
Long-term Debt17.15B15.23B11.09B10.37B9.68B
Deferred Tax Liabilities962M661M403M103M245M
Deferred Revenue (Non-current)84M40M41M40M36M
Other Non-current Liabilities1.45B1.27B1.51B1.49B783M
Total Non-current Liabilities20.16B17.65B13.31B12.25B10.98B
Total Liabilities24.4B22.39B19.81B18.76B13.95B
Common Stock683M683M683M683M683M
Retained Earnings17.07B14.05B16.11B14.93B13.71B
Accumulated OCI(3.38B)(3.83B)(3.55B)(4.01B)(3.75B)
Other Stockholders Equity00000
Minority Interest44M62M66M60M(27M)
Total Equity9.12B5.9B8.47B7.02B6.1B
Total Debt18.31B17.2B14.11B13.45B10B
Net Debt15.36B15.49B11.04B11.69B8.04B

Baxter International Inc.

NYSE:BAX

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.